A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
Clinical trial NCT06716190 · TERMINATED
Trial details
- NCT number
- NCT06716190
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-05-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.